TY  - CONF

T1  - The Cost-Effectiveness of Biologic DMARDs in Patients With Severe or Mild-To-Severe Rheumatoid Arthritis After Conventional DMARDs

CY  - Amsterdam, The Netherlands

PY  - 2014/01/01

AU  - Wailoo AJ

AU  - Stevenson M

AU  - Tosh J

AU  - Hernández M

AU  - Stevens JW

AU  - Archer R

AU  - Simpson E

AU  - Everson Hock E

AU  - Scott D

AU  - Young A

AU  - Paisley S  et al

ED  - 

VL  - Value in Health, Vol. 17, Issue 7, A380

Y2  - 2024/12/22

ER  -